MarketWatch

The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.

Japan’s pension titan selling foreign assets could push U.S. yields up and sap demand for the dollar.

Lockheed Martin’s stock jumps as a ramp up in missile production helped lead to an earnings beat and raise.

Brent crude rose to over $98 a barrel following the news that the rebel group attacked the vessels in the Red Sea.

The huge premium commanded by SK Hynix ‘s American depository receipts over its domestically-listed ordinary shares is likely to remain, after restrictions were put in place on the number of ADRs that can be created by converting local shares.

The different price action between artificial-intelligence hyperscalers and chip and infrastructure stocks is a throwback to a setup in the late 1990s, argues JPMorgan.

The wireless carrier has focused on amassing “higher quality accounts” after introducing new plans last year.